Efficacy of FP-025: A novel matrix metalloproteinase-12 (MMP-12) inhibitor in murine allergic asthma

Allergy. 2023 Feb;78(2):559-562. doi: 10.1111/all.15513. Epub 2022 Sep 18.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Asthma* / drug therapy
  • Humans
  • Lung
  • Matrix Metalloproteinase 12*
  • Mice
  • Sulfur Compounds
  • Tissue Inhibitor of Metalloproteinase-1

Substances

  • FP-025
  • Matrix Metalloproteinase 12
  • Sulfur Compounds
  • Tissue Inhibitor of Metalloproteinase-1